Dr. Ami Kurzweil, MD

Dr. Kurzweil practices at Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center.

Dr. Kurzweil's NPI, 1982058384, was assigned on April 21, 2016. Dr. Kurzweil holds California license A160117.

Dr. Kurzweil's primary practice is Eisenhower Health, at 39-000 Bob Hope Drive, Rancho Mirage, CA 92270 in Riverside County. The practice phone is (760) 340-3911. Dr. Kurzweil also practices at Eisenhower Medical Center, 39000 Bob Hope Dr, Rancho Mirage, CA 92270.

Dr. Kurzweil's primary practice is Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center. The medical group on file is Eisenhower Health. Dmand AI also links Dr. Kurzweil to 3 more medical groups, 1 breast imaging center, 1 clinical lab and 1 dialysis center, each named with a free account. Dr. Kurzweil's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kurzweil practices, 4 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Kurzweil's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Kurzweil is licensed in California.

CMS data shows 516 Medicare services from Dr. Kurzweil across 6 procedure codes in 2024, for 405 Medicare patients. Medicare paid $61,535 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 405 Medicare patients who saw Dr. Kurzweil in 2024. The largest group is 75 to 84, with 148 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kurzweil's median patient age at 60, with 53% women.

In 2024, Dr. Kurzweil wrote 117 Medicare Part D claims for 81 patients. 95% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $69 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Kurzweil for performance year 2024, reported as part of a group. Dr. Kurzweil accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Kurzweil from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Mindray DS USA, Inc. paid the most, $32.